IL163865A0 - Compositions comprising a non-ionicsurfactant and n-docosanol - Google Patents

Compositions comprising a non-ionicsurfactant and n-docosanol

Info

Publication number
IL163865A0
IL163865A0 IL16386597A IL16386597A IL163865A0 IL 163865 A0 IL163865 A0 IL 163865A0 IL 16386597 A IL16386597 A IL 16386597A IL 16386597 A IL16386597 A IL 16386597A IL 163865 A0 IL163865 A0 IL 163865A0
Authority
IL
Israel
Prior art keywords
alcohol
docosanol
active ingredient
compositions
nonionic surfactant
Prior art date
Application number
IL16386597A
Other languages
English (en)
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/916,624 external-priority patent/US5952392A/en
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of IL163865A0 publication Critical patent/IL163865A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16386597A 1996-09-17 1997-09-10 Compositions comprising a non-ionicsurfactant and n-docosanol IL163865A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71500996A 1996-09-17 1996-09-17
US08/916,624 US5952392A (en) 1996-09-17 1997-08-22 Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
PCT/US1997/016007 WO1998011887A2 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides

Publications (1)

Publication Number Publication Date
IL163865A0 true IL163865A0 (en) 2005-12-18

Family

ID=27109257

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16386597A IL163865A0 (en) 1996-09-17 1997-09-10 Compositions comprising a non-ionicsurfactant and n-docosanol
IL12903397A IL129033A0 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols alkanes fatty acids and amides

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12903397A IL129033A0 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols alkanes fatty acids and amides

Country Status (16)

Country Link
EP (2) EP1557167A1 (xx)
JP (1) JP3739098B2 (xx)
KR (2) KR100528816B1 (xx)
CN (1) CN1213748C (xx)
AT (1) ATE299700T1 (xx)
AU (1) AU742929B2 (xx)
BR (1) BR9711501A (xx)
CA (1) CA2273960C (xx)
DE (1) DE69733778T2 (xx)
DK (1) DK1001759T3 (xx)
ES (1) ES2245004T3 (xx)
IL (2) IL163865A0 (xx)
MX (1) MXPA99002575A (xx)
PL (1) PL189618B1 (xx)
PT (1) PT1001759E (xx)
WO (1) WO1998011887A2 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
WO1998020872A1 (en) 1996-11-14 1998-05-22 Halldor Thormar Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
ES2202872T3 (es) * 1997-06-20 2004-04-01 Prometics Bodycare Limited Composicion protectora de la piel.
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
SE0102289D0 (sv) * 2001-06-27 2001-06-27 Anders Hamberger New use of compound
NZ532944A (en) * 2001-10-16 2005-10-28 Avanir Pharmaceuticals Stable, topical formulation for treating viral and inflammatory conditions comprising 10% n-docosanol, 5% of a stearate, 8% mineral oil, 5% propylene glycol, 2.7% benzyl alcohol and water
EP1551495A4 (en) 2002-10-10 2010-06-02 Yeda Res & Dev BASIC ESTERS OF FAT ALCOHOLS AND THEIR USE AS ANTI-INFLAMMATORY OR IMMUNOMATORY AGENTS
KR200449517Y1 (ko) * 2008-01-23 2010-07-15 김영중 선박의 조향장치용 헬름
KR100971276B1 (ko) * 2008-05-29 2010-07-20 김영중 조향장치
WO2011112997A1 (en) 2010-03-11 2011-09-15 Chemic Laboratories, Inc. Novel compositions and methods
CN102702061B (zh) * 2012-06-07 2013-04-24 浙江维康药业有限公司 一种盐酸水苏碱化合物及含有该化合物的药物组合物
JP6125962B2 (ja) * 2013-09-24 2017-05-10 株式会社デンソー 抗ウイルス剤
FR3080038B1 (fr) 2018-04-16 2020-10-09 Oreal Composition cosmetique pour fibres keratiniques
FR3080034B1 (fr) * 2018-04-16 2020-04-24 L'oreal Composition cosmetique pour fibres keratiniques
KR102611242B1 (ko) * 2021-05-17 2023-12-08 충남대학교 산학협력단 알케인을 유효성분으로 함유하는 항바이러스용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
CA2153780C (en) * 1993-01-15 2004-04-13 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
DK1473031T3 (da) * 1993-12-13 2008-10-20 Avanir Pharmaceuticals Sucroseester - C20 til C28 alkoholformuleringer

Also Published As

Publication number Publication date
KR20030097605A (ko) 2003-12-31
DE69733778D1 (de) 2005-08-25
DE69733778T2 (de) 2006-04-20
AU4339797A (en) 1998-04-14
DK1001759T3 (da) 2005-10-10
EP1557167A1 (en) 2005-07-27
KR100528815B1 (ko) 2005-11-16
CA2273960A1 (en) 1998-03-26
AU742929B2 (en) 2002-01-17
CA2273960C (en) 2003-12-30
ATE299700T1 (de) 2005-08-15
WO1998011887A3 (en) 1998-06-25
EP1001759A2 (en) 2000-05-24
EP1001759B1 (en) 2005-07-20
IL129033A0 (en) 2000-02-17
CN1213748C (zh) 2005-08-10
JP2001521490A (ja) 2001-11-06
KR100528816B1 (ko) 2005-11-16
KR20000036210A (ko) 2000-06-26
BR9711501A (pt) 2004-05-25
PL332455A1 (en) 1999-09-13
PL189618B1 (pl) 2005-08-31
JP3739098B2 (ja) 2006-01-25
PT1001759E (pt) 2005-10-31
MXPA99002575A (es) 2004-07-29
CN1244121A (zh) 2000-02-09
ES2245004T3 (es) 2005-12-16
WO1998011887A2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
IL163865A0 (en) Compositions comprising a non-ionicsurfactant and n-docosanol
EP0264904A3 (en) Pharmaceutical compositions containing benzoyl urea derivatives
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
NZ241169A (en) Substituted azole derivatives, preparatory processes and pharmaceutical compositions
MY121192A (en) New compounds.
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
NZ236605A (en) 2-aminopyrimidine-4-carboxamide derivatives, preparation and pharmaceutical compositions thereof
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
CA2063273A1 (en) Surfactant compositions and methods
DE3361757D1 (en) Salicylic-acid derivatives, process for their preparation, pharmaceutical preparations based on these compounds and their use
MY132819A (en) Pharmaceutical compositions containing n-sulphonylindoline derivatives
TW252979B (xx)
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
YU82693A (sh) Farmaceutske formulacije disulfonil metana i novi disulfonil metani
HUT74710A (en) Herbicidal pyrrolopyridine compounds, compositions containing them and use thereof
ATE282608T1 (de) Chinoxalindionen
EP1486203A3 (en) Surfactant compounds and uses thereof
YU79602A (xx) Tip 1 (nhe-1) inhibitor natrijum-vodonik izmenjiva^a
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
WO2003035043A3 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
IL98394A0 (en) Ws7622a mono or di-sulfate,salts thereof,processes for the preparation thereof and pharmaceutical compositions containing the same
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use